Bryson W. Katona

Harnessing the hidden antitumor power of the MLL-AF4 oncogene to fight leukemia.

EZH2 inhibition enhances the efficacy of an EGFR inhibitor in suppressing colon cancer cells.

Menin-mediated regulation of miRNA biogenesis uncovers the IRS2 pathway as a target for regulating pancreatic beta cells.

Gastric Cancer Genomics: Advances and Future Directions.

Colorectal cancer risk associated with the CHEK2 1100delC variant.

Efficacy of Peptide Receptor Radionuclide Therapy in a United States-Based Cohort of Metastatic Neuroendocrine Tumor Patients: Single-Institution Retrospective Analysis.

Two Types of Gastric Cancer Caused by the Same Underlying Condition.

A counseling framework for moderate-penetrance colorectal cancer susceptibility genes.

Identification of a novel GREM1 duplication in a patient with multiple colon polyps.

Earlier Colorectal Cancer Screening May Be Necessary In Patients With Li-Fraumeni Syndrome.

RE: BRCA1 and BRCA2 Gene Mutations and Colorectal Cancer Risk: Systematic Review and Meta-analysis.

Combined Menin and EGFR Inhibitors Synergize to Suppress Colorectal Cancer via EGFR-Independent and Calcium-Mediated Repression of SKP2 Transcription.

The role of endoscopy in the management of hereditary diffuse gastric cancer syndrome.

Islet-specific Prmt5 excision leads to reduced insulin expression and glucose intolerance in mice.

Chemoprevention of Colorectal Cancer.

Genetic testing for hereditary gastrointestinal cancer syndromes: Interpreting results in today's practice.

Menin: Expanding and dichotomous roles in cancer.

CDH1 on Multigene Panel Testing: Look Before You Leap.

Loss-of-function variants in CTNNA1 detected on multigene panel testing in individuals with gastric or breast cancer.

Associations of sociodemographic and clinical factors with gastrointestinal cancer risk assessment appointment completion.

Multifocal Intramucosal Gastric Adenocarcinoma Arising in Fundic Gland Polyposis Due to Gastric Adenocarcinoma and Proximal Polyposis of the Stomach.

Upper Endoscopic Surveillance in Lynch Syndrome Detects Gastric and Duodenal Adenocarcinomas.

Menin-mediated Repression of Glycolysis in Combination with Autophagy Protects Colon Cancer Against Small-molecule EGFR Inhibitors.

Upper Gastrointestinal Cancer Risk and Surveillance Outcomes in Li-Fraumeni Syndrome.

Phenotypic Differences in Juvenile Polyposis Syndrome With or Without a Disease-causing / Variant.

COVID-19 Disruptions to Endoscopic Surveillance in Lynch Syndrome.

Menin-regulated Pbk controls high fat diet-induced compensatory beta cell proliferation.

Upper gastrointestinal cancers in Lynch syndrome: the time for surveillance is now.

COVID-19 related pancreatic cancer surveillance disruptions amongst high-risk individuals.

Multigene Panel Testing in Individuals With Hepatocellular Carcinoma Identifies Pathogenic Germline Variants.

EUS-based Pancreatic Cancer Surveillance in Carriers Without a Family History of Pancreatic Cancer.

Screening for Pancreatic Ductal Adenocarcinoma: Are We Asking the Impossible?-Letter.

THSB2 as a prognostic biomarker for patients diagnosed with metastatic pancreatic ductal adenocarcinoma.

Prolactin-regulated Pbk is involved in pregnancy-induced β-cell proliferation in mice.

Evaluation of Classic, Attenuated, and Oligopolyposis of the Colon.

Uptake and outcomes of small intestinal and urinary tract cancer surveillance in Lynch syndrome.

Detection of Early-Stage Pancreatic Ductal Adenocarcinoma From Blood Samples: Results of a Multiplex Biomarker Signature Validation Study.

Patterns of germline and somatic testing after universal tumor screening for Lynch syndrome: A clinical practice survey of active members of the Collaborative Group of the Americas on Inherited Gastrointestinal Cancer.

Yield of upper gastrointestinal screening in colonic adenomatous polyposis of unknown etiology: a multicenter study.

The Multicenter Cancer of Pancreas Screening Study: Impact on Stage and Survival.

First estimates of diffuse gastric cancer risks for carriers of germline pathogenic variants.

Reaching beyond family history as inclusion criteria for pancreatic cancer surveillance in high-risk populations.

Outcomes of upper endoscopy screening in Lynch syndrome: a meta-analysis.

Gastroenteropancreatic Neuroendocrine Tumors.

Summary of the experiences, knowledge, medical management, and family communication of monoallelic MUTYH carriers.

Reply to S. Raoof.

Correction: THBS2 as a prognostic biomarker for patients diagnosed with metastatic pancreatic ductal adenocarcinoma.

Multigene Panel Testing Yields High Rates of Clinically Actionable Variants Among Patients With Colorectal Cancer.

Gastric Cancer Risk and Pathogenesis in and Carriers.

The Approach to Performance of Quality Upper Endoscopy in Lynch Syndrome (QUELS): An International Expert Statement.

Comparing telemedicine and in-person gastrointestinal cancer genetic appointment outcomes during the COVID-19 pandemic.

Racial, Ethnic, and Sex-based Disparities among High-risk Individuals Undergoing Pancreatic Cancer Surveillance.

Current chemoprevention approaches in Lynch syndrome and Familial adenomatous polyposis: a global clinical practice survey.

Combining clinical and molecular characterization of CDH1: a multidisciplinary approach to reclassification of a splicing variant.

Preventive strategies in familial and hereditary colorectal cancer.

Outcomes of the IMMray PanCan-d Test in High-Risk Individuals Undergoing Pancreatic Surveillance: Pragmatic Data and Lessons Learned.

Exploring Stakeholders' Perspectives on Implementing Universal Germline Testing for Colorectal Cancer: Findings From a Clinical Practice Survey.

Rebranding Colonic Polyposis of Unknown Etiology: The Dawn of Idiopathic Adenomatous Polyposis.

Prediction of Lu-DOTATATE Therapy Outcomes in Neuroendocrine Tumor Patients Using Semi-Automatic Tumor Delineation on Ga-DOTATATE PET/CT.